Pharmacometabolomics applied to zonisamide pharmacokinetic parameter prediction

Valora este artículo
0 / 5 (0 votos)

DOI: 10.1007/s11306-018-1365-5
Fecha: 9 Mayo 2018
Revista: Metabolomics
Autores: J. C. Martínez-Ávila, A. García Bartolomé, I. García, I. Dapía, Hoi Y. Tong, L. Díaz, P. Guerra, J. Frías, A. J. Carcás Sansuan, A. M. Borobia

Zonisamide is a new-generation anticonvulsant antiepileptic drug metabolized primarily in the liver, with subsequent elimination via the renal route.

Objectives: Our objective was to evaluate the utility of pharmacometabolomics in the detection of zonisamide metabolites that could be related to its disposition and therefore, to its efficacy and toxicity.

Seguir leyendo